Pain Therapeutics: Clinical Trials

16 trials sponsored by Pain Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 13 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 113Completed 13
Phase 22Completed 2
Phase 31Completed 1

Follow Pain Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
PTI-125, 100 mg tablets - Alzheimer Disease
Phase 2CompletedPain Therapeutics132019-03-072021-07-07
A Safety Study of PTI-125 in Healthy Volunteers
50 mg PTI-125, 100 mg PTI-125, 200 mg PTI-125 - Alzheimer Disease, Early Onset, Alzheimer Disease
Phase 1CompletedPain Therapeutics242017-08-182021-05-10
Nasal Human Abuse Potential of PTI-821
PTI-821 capsule Manipulated, PTI-821 Non-manipulated, OxyContin - Opioid Abuse Nondependent
Phase 1CompletedPain Therapeutics382017-05-152018-03-23
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Oxycodone, Naltrexone - Healthy
Phase 1CompletedPain Therapeutics172014-07-012016-04-04
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
Oxycodone - Healthy
Phase 1CompletedPain Therapeutics182014-04-012016-04-04
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
Oxycodone - Healthy
Phase 1CompletedPain Therapeutics342014-04-012016-04-04
Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
Oxycodone - Healthy
Phase 1CompletedPain Therapeutics1342014-04-012016-04-04
Abuse Potential Study of PF-00345439
Capsule, PF-00345439, oxycodone - Opioid Users
Phase 1CompletedPain Therapeutics672013-11-012016-04-04
Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
Oxycodone - Healthy
Phase 1CompletedPain Therapeutics182013-08-012015-08-31
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
Oxycodone - Healthy
Phase 1CompletedPain Therapeutics192012-11-012015-08-31
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone
Oxycodone - Pain
Phase 1CompletedPain Therapeutics182012-04-012015-08-31
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
Oxycodone - Pain
Phase 1CompletedPain Therapeutics212012-03-012015-08-31
Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
PTI-6D2 - Metastatic Melanoma
Phase 1CompletedPain Therapeutics212009-01-012011-07-14
Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse
oxycodone and naltrexone - Opioid-Related Disorders
Phase 2CompletedPain Therapeutics142007-08-012016-05-02
Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
188Re-PTI-6D2 - Metastatic Melanoma
Phase 1CompletedPain Therapeutics122007-05-012011-07-14
Long-term Safety of PF-00345439 (Oxycodone)
PF-00345439 - Pain
Phase 3CompletedPain Therapeutics8232006-04-012015-09-11

Conditions studied

Pain (3)  ·  Alzheimer Disease (2)  ·  Melanoma (2)  ·  Opioid-Related Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Oxycodone (12)  ·  Naltrexone (2)  ·  Simufilam (2)  ·  Capsules (1)

Countries

United States (12)  ·  Israel (2)  ·  Singapore (1)

Top investigators

Eithan Galun, M.D. (2)  ·  George E Bigelow, PhD (1)  ·  George J Atiee, MD (1)  ·  Jacob Schachter, M.D. (1)  ·  Lindsay Burns, PhD (1)  ·  Lynn Webster, MD (1)  ·  Tzila Zwas, M.D. (1)

Results publications

PMID 32920628

NIH funding

R44AG056166 (1), R44AG060878 (1)